Long-term follow-up of a randomized trial of fludarabine–mitoxantrone, compared with cyclophosphamide, doxorubicin, vindesine, prednisone (CHVP), as first-line treatment of elderly patients with advanced, low-grade non-Hodgkin's lymphoma before the era of monoclonal antibodies
| Autor: | Foussard, C. 1, Colombat, P. 2, Maisonneuve, H. 3, Berthou, C. 4, Gressin, R. 5, Rousselet, M.-C. 6, Rachieru, P. 1, Pignon, B. 7, Mahé, B. 8, Ghandour, C. 9, Desablens, B. 10, Casassus, P. 11, Lamy, T. 12, Delwail, V. 13, Deconinck, E. 14, * |
|---|---|
| Zdroj: | In Annals of Oncology March 2005 16(3):466-472 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|